Biosimilar Market Size 2022-27: Trends, Share, Growth, Opportunity and Forecast
According to the recent report by IMARC Group, entitled “ Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the global biosimilar market size was estimated to be US$ 13.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting at a CAGR of 26.1% during 2022-2027. Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc. We are regularly track...